Humans survived evolution without vitamin D-rich food or without vitamin D supplementation until vitamin D deficiency, rickets, became a major health problem from the 17th century onwards [1] . During the 20 th century, it became clear that exposure to sunlight and UVB should be avoided (infants and young children), or limited because of life time risks of skin damage or skin cancers. Moreover, voluntary avoidance (e.g. for cultural or religious reasons) of sun exposure or mismatch between skin color and climate (dark skinned immigrants living in Northern or Southern latitudes) severely limits the endogenous production of vitamin D well below the normal vitamin D requirements. This cannot be compensated by promoting natural vitamin D-rich food as there is simply not enough fatty fish in the ocean. Therefore vitamin D supplementation (either as vitamin D enriched food or by intake of supplements) will remain necessary for all infants and young children, for most elderly subjects and for other risk groups [2, 3] . The major remaining questions are the overall health implications of vitamin D beyond bone health, the precise requirements (and thus the definition of vitamin D deficiency and the associated serum 25OHD concentrations) and the practical modalities to implement and maintain this supplementation for many years or for a lifetime to millions or even billions of people in a cost efficient way. Vitamin D is rapidly cleared from the circulation after its oral intake but it has nevertheless a long biological life time and its major metabolite, 25OHD, has a half-life of about 2 weeks [4] . As to enhance compliance, high dose intermittent therapy (once every 6-12 months) has been introduced in the past but several recent studies documented either transient hypercalcemia in children [5] or transient increased risks of falls or fractures [6, 7] and therefore this strategy is no longer a valid option. Daily, weekly or monthly use of vitamin D (in equivalent cumulative dosage) could enhance long term compliance depending on the behavior or preference of the target groups. Whether such intermittent therapy generates the same vitamin D status has been studied by a group of Hungarian scientists [8] . They randomized modestly vitamin D deficient adults (mean age 53 years; mean baseline 25OHD of~13 ng/ml) to receive either daily (1000 IU), weekly (7000 IU) or monthly (30,000 IU) doses of vitamin D 3 and found very similar increase in the serum 25OHD after 3 months. This conclusion was essentially the same whether or not the data were corrected for several potentially confounding factors. The increase in serum 25OHD was about 1.3 ng/100 IU, in line with most previous studies in subjects with a similarly low baseline vitamin D status. The results confirm a previous (equally small) study in elderly subjects (mean age of 80 years [9] ), whereas others found a slightly lower efficacy of monthly compared to daily or weekly doses [10] . Collectively, however, these reports confirm that these strategies yield essentially similar results especially when taking into account the wide interindividual differences. Such choice of options thus may guide clinicians to find optimal long-term compliance. Although Hollis claimed that steady supply of vitamin D may be more beneficial than intermittent dosage [11] , such intermittent therapy may resemble the natural intermittent endogenous production of vitamin depending on the intermittent exposure to natural sunlight or access to vitamin D rich food sources. The dosage
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